MedTrace Logo

Bone Marrow for Hemoglobinopathy Research

NCT00669305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2020-02-25

No results posted yet for this study

Summary

Human participants affected with sickle cell disease or thalassemia will donate bone marrow for use in experimental laboratory models to study potential new treatments. This is an observational study using bone marrow from human participants. The investigators will use sickle cell and thalassemia mouse models to observe and evaluate the possibility of correcting these disorders through genetic alterations or drug treatment.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Assisi Foundation

    collaborator OTHER

  • University of Tennessee

    collaborator OTHER

  • St. Jude Children's Research Hospital

    lead OTHER

Principal Investigators

  • Mitchell J. Weiss, MD, PhD · St. Jude Children's Research Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-15
Primary Completion
2019-08-29
Completion
2019-08-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00669305 on ClinicalTrials.gov